← Back to Search

Neuroimaging for Migraine

N/A

Waitlist Available

Led By Catherine Chong, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Female only.

Ages 20-45 years.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial is investigating whether WMH are more common in women with migraines, and if so, what characteristics they have.

Who is the study for?

This study is specifically for women aged 20-45 who have white matter hyperintensities (WMH) on their brain MRI, which can be related to conditions like migraines or small vessel disease.Check my eligibility

What is being tested?

The trial is focused on using brain neuroimaging techniques to investigate the presence and characteristics of WMH in women suffering from migraines.See study design

What are the potential side effects?

Since this trial involves non-invasive brain imaging, there are minimal side effects. Participants may experience discomfort from lying still during the MRI procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am female.

Select...

I am between 20 and 45 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

WMH imaging disease parameters

Trial Design

3Treatment groups

Experimental Treatment

Group I: Small vessel ischemic (SVI) disease cohortExperimental Treatment1 Intervention

Women diagnosed with SVI disease and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.

Group II: Multiple sclerosis (MS) cohortExperimental Treatment1 Intervention

Women diagnosed with MS and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.

Group III: Migraine cohortExperimental Treatment1 Intervention

Women with migraine and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,221 Previous Clinical Trials

3,769,090 Total Patients Enrolled

9 Trials studying Migraine

81,756 Patients Enrolled for Migraine

Catherine Chong, PhDPrincipal InvestigatorMayo Clinic

1 Previous Clinical Trials

260 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers accepting new enrollees for this research endeavor?

"Affirmative. Clinicaltrials.gov states that this clinical test, first uploaded on August 16th 2021, is actively looking for volunteers to take part in the study. Currently, there are 50 spots available at a single trial site."

Answered by AI

How many participants are being observed for this research study?

"Affirmative. This clinical trial, that was initially posted on August 16th 2021, is actively searching for enrollees. 50 participants must be recruited from a single medical facility according to the data currently hosted on clinicaltrials.gov."

Answered by AI

Is this research open to individuals in their senior years?

"According to the study's prerequisites, potential applicants must be between 20 and 59 years of age. Furthermore, 58 studies are available for people under 18 while 361 studies can cater to participants over 65."

Answered by AI

What criteria do participants need to meet in order to be eligible for this clinical trial?

"This migraine trial is seeking 50 female candidates aged between 20 and 45."

Answered by AI

Who else is applying?

What site did they apply to?

Mayo Clinic in Arizona

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

For multiple years, have been treated unsuccessfully for chronic irretractable migraines for more than 25 days out of the month now with introduction of possible MS and MRI, showing small vascular disease, I am curious about finding out more about the trail, as I am desperate for pain, relief.

PatientReceived 1 prior treatment

Recent research and studies

clinicaltrials.govStudy

A Study to Evaluate White Matter Hyperintensities in Migraine

Catherine (Cat) Chong 2021. "A Study to Evaluate White Matter Hyperintensities in Migraine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05112289.

All > Migraine Headaches > Migraine